BROGI, SIMONE Statistiche
BROGI, SIMONE
DIPARTIMENTO DI FARMACIA
A novel potent class I HDAC inhibitor reverses the STAT4/p66Shc apoptotic defect in B cells from chronic lymphocytic leukemia patients
2024-01-01 Rossi, S.; Tatangelo, V.; Dichiara, M.; Butini, S.; Gemma, S.; Brogi, S.; Pasquini, S.; Cappello, M.; Vincenzi, F.; Varani, K.; Lopresti, L.; Malchiodi, M.; Carrara, C.; Gozzetti, A.; Bocchia, M.; Marotta, G.; Patrussi, L.; Carullo, G.; Baldari, C. T.; Campiani, G.
A virtual insight into mushroom secondary metabolites: 3D-QSAR, docking, pharmacophore-based analysis and molecular modeling to analyze their anti-breast cancer potential
2024-01-01 Shafiq, N.; Shakoor, B.; Yaqoob, N.; Parveen, S.; Brogi, S.; Mohammad Salamatullah, A.; Rashid, M.; Bourhia, M.
Development of Potent and Selective Monoacylglycerol Lipase Inhibitors. SARs, Structural Analysis, and Biological Characterization
2024-01-01 Butini, S.; Grether, U.; Jung, K. -M.; Ligresti, A.; Allara, M.; Postmus, A. G. J.; Maramai, S.; Brogi, S.; Papa, A.; Carullo, G.; Sykes, D.; Veprintsev, D.; Federico, S.; Grillo, A.; Di Guglielmo, B.; Ramunno, A.; Stevens, A. F.; Heer, D.; Lamponi, S.; Gemma, S.; Benz, J.; Di Marzo, V.; van der Stelt, M.; Piomelli, D.; Campiani, G.
Editorial: Design and development of new therapeutics against infectious diseases using computational and experimental approaches
2024-01-01 Brogi, S.; Sen Gupta, P. S.; Mishra, Y. K.
Exploring Citrus sinensis Phytochemicals as Potential Inhibitors for Breast Cancer Genes BRCA1 and BRCA2 Using Pharmacophore Modeling, Molecular Docking, MD Simulations, and DFT Analysis
2024-01-01 Zia, M.; Parveen, S.; Shafiq, N.; Rashid, M.; Farooq, A.; Dauelbait, M.; Shahab, M.; Salamatullah, A. M.; Brogi, S.; Bourhia, M.
Globospiramine Exhibits Inhibitory and Fungicidal Effects against Candida albicans via Apoptotic Mechanisms
2024-01-01 Manzano, J. A. H.; Brogi, S.; Calderone, V.; Macabeo, A. P. G.; Austriaco, N.
Globospiramine from Voacanga globosa Exerts Robust Cytotoxic and Antiproliferative Activities on Cancer Cells by Inducing Caspase-Dependent Apoptosis in A549 Cells and Inhibiting MAPK14 (p38α): In Vitro and Computational Investigations
2024-01-01 Manzano, J. A. H.; Abellanosa, E. A.; Aguilar, J. P.; Brogi, S.; Yen, C. -H.; Macabeo, A. P. G.; Austriaco, N.
Intermittent Fasting: Myths, Fakes and Truth on This Dietary Regimen Approach
2024-01-01 Brogi, S.; Tabanelli, R.; Puca, S.; Calderone, V.
Lithocholic acid derivatives as potent modulators of the nuclear receptor RORγt
2024-01-01 Abdel-Rahman, S. A.; Brogi, S.; Gabr, M. T.
Multi-Technique Approach to Identify Potent Antimicrobial Agents from Calotropis procera: Insight into Pharmacophore Modeling, Molecular docking, MD simulation, and DFT Approaches
2024-01-01 Rashid, M.; Sajjad, N.; Shafiq, N.; Parveen, S.; Khan, R. A.; Farooq, A.; Shaha, M.; Dawoud, T. M.; Brogi, S.; Bourhia, M.
Natural products as non-covalent and covalent modulators of the KEAP1/NRF2 pathway exerting antioxidant effects
2024-01-01 Culletta, G.; Buttari, B.; Arese, M.; Brogi, S.; Almerico, A. M.; Saso, L.; Tutone, M.
Synthesis, enzyme inhibition assay, and molecular modeling study of novel pyrazolines linked to 4-methylsulfonylphenyl scaffold: antitumor activity and cell cycle analysis
2024-01-01 Abdel-Aziz, A. A.; El-Azab, A. S.; Brogi, S.; Ayyad, R. R.; Alkahtani, H. M.; Abuelizz, H. A.; Al-Suwaidan, I. A.; Al-Obaid, A. M.
Targeting Relevant HDACs to Support the Survival of Cone Photoreceptors in Inherited Retinal Diseases: Identification of a Potent Pharmacological Tool with In Vitro and In Vivo Efficacy
2024-01-01 Carullo, G.; Orsini, N.; Piano, I.; Pozzetti, L.; Papa, A.; Fontana, A.; Napoli, D.; Corsi, F.; Marco, B. D.; Galante, A.; Marotta, L.; Panzeca, G.; O'Brien, J.; Sanchez, A. G.; Doherty, H.; Mahon, N.; Clarke, L.; Contri, C.; Pasquini, S.; Gorelli, B.; Saponara, S.; Valoti, M.; Vincenzi, F.; Varani, K.; Ramunno, A.; Brogi, S.; Butini, S.; Gemma, S.; Kennedy, B. N.; Gargini, C.; Strettoi, E.; Campiani, G.
Characterization of stenocephol from Seriphidium stenocephalum as potent HepG2 cell growth and glycogen phosphorylase inhibitor
2023-01-01 Shafiq, N.; Arshad, U.; Brogi, S.; Rashid, M.; Rafiq, N.; Parveen, S.
Computation to Fight SARS-CoV-2 (COVID-19)
2023-01-01 Brogi, S.; Calderone, V.
Design, synthesis, and biological investigation of oxadiazolyl, thiadiazolyl, and pyrimidinyl linked antipyrine derivatives as potential non-acidic anti-inflammatory agents
2023-01-01 Al-Sanea, M. M.; Hamdi, A.; Brogi, S.; S Tawfik, S.; Othman, D. I. A.; Elshal, M.; Ur Rahman, H.; Parambi, D. G. T.; M Elbargisy, R.; Selim, S.; Mostafa, E. M.; Mohamed, A. A. B.
Development of Quinazolinone Derivatives as Modulators of Virulence Factors of Pseudomonas aeruginosa Cystic Fibrosis Strains
2023-01-01 Carullo, G.; Di Bonaventura, G.; Rossi, S.; Lupetti, V.; Tudino, V.; Brogi, S.; Butini, S.; Campiani, G.; Gemma, S.; Pompilio, A.
Developmental landscape of computational techniques to explore the potential phytochemicals from Punica granatum peels for their antioxidant activity in Alzheimer’s disease
2023-01-01 Parveen, S.; Batool, A.; Shafiq, N.; Rashid, M.; Sultan, A.; Wondmie, G. F.; Bin Jardan, Y. A.; Brogi, S.; Bourhia, M.
Discovery of novel direct small-molecule inhibitors targeting HIF-2α using structure-based virtual screening, molecular dynamics simulation, and MM-GBSA calculations
2023-01-01 Yazdani, B.; Sirous, H.; Enguita, F. J.; Brogi, S.; Wing, P. A. C.; Fassihi, A.
Disruption of Irisin Dimerization by FDA-Approved Drugs: A Computational Repurposing Approach for the Potential Treatment of Lipodystrophy Syndromes
2023-01-01 Flori, L.; Brogi, S.; Sirous, H.; Calderone, V.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A novel potent class I HDAC inhibitor reverses the STAT4/p66Shc apoptotic defect in B cells from chronic lymphocytic leukemia patients | 1-gen-2024 | Rossi, S.; Tatangelo, V.; Dichiara, M.; Butini, S.; Gemma, S.; Brogi, S.; Pasquini, S.; Cappello, M.; Vincenzi, F.; Varani, K.; Lopresti, L.; Malchiodi, M.; Carrara, C.; Gozzetti, A.; Bocchia, M.; Marotta, G.; Patrussi, L.; Carullo, G.; Baldari, C. T.; Campiani, G. | |
| A virtual insight into mushroom secondary metabolites: 3D-QSAR, docking, pharmacophore-based analysis and molecular modeling to analyze their anti-breast cancer potential | 1-gen-2024 | Shafiq, N.; Shakoor, B.; Yaqoob, N.; Parveen, S.; Brogi, S.; Mohammad Salamatullah, A.; Rashid, M.; Bourhia, M. | |
| Development of Potent and Selective Monoacylglycerol Lipase Inhibitors. SARs, Structural Analysis, and Biological Characterization | 1-gen-2024 | Butini, S.; Grether, U.; Jung, K. -M.; Ligresti, A.; Allara, M.; Postmus, A. G. J.; Maramai, S.; Brogi, S.; Papa, A.; Carullo, G.; Sykes, D.; Veprintsev, D.; Federico, S.; Grillo, A.; Di Guglielmo, B.; Ramunno, A.; Stevens, A. F.; Heer, D.; Lamponi, S.; Gemma, S.; Benz, J.; Di Marzo, V.; van der Stelt, M.; Piomelli, D.; Campiani, G. | |
| Editorial: Design and development of new therapeutics against infectious diseases using computational and experimental approaches | 1-gen-2024 | Brogi, S.; Sen Gupta, P. S.; Mishra, Y. K. | |
| Exploring Citrus sinensis Phytochemicals as Potential Inhibitors for Breast Cancer Genes BRCA1 and BRCA2 Using Pharmacophore Modeling, Molecular Docking, MD Simulations, and DFT Analysis | 1-gen-2024 | Zia, M.; Parveen, S.; Shafiq, N.; Rashid, M.; Farooq, A.; Dauelbait, M.; Shahab, M.; Salamatullah, A. M.; Brogi, S.; Bourhia, M. | |
| Globospiramine Exhibits Inhibitory and Fungicidal Effects against Candida albicans via Apoptotic Mechanisms | 1-gen-2024 | Manzano, J. A. H.; Brogi, S.; Calderone, V.; Macabeo, A. P. G.; Austriaco, N. | |
| Globospiramine from Voacanga globosa Exerts Robust Cytotoxic and Antiproliferative Activities on Cancer Cells by Inducing Caspase-Dependent Apoptosis in A549 Cells and Inhibiting MAPK14 (p38α): In Vitro and Computational Investigations | 1-gen-2024 | Manzano, J. A. H.; Abellanosa, E. A.; Aguilar, J. P.; Brogi, S.; Yen, C. -H.; Macabeo, A. P. G.; Austriaco, N. | |
| Intermittent Fasting: Myths, Fakes and Truth on This Dietary Regimen Approach | 1-gen-2024 | Brogi, S.; Tabanelli, R.; Puca, S.; Calderone, V. | |
| Lithocholic acid derivatives as potent modulators of the nuclear receptor RORγt | 1-gen-2024 | Abdel-Rahman, S. A.; Brogi, S.; Gabr, M. T. | |
| Multi-Technique Approach to Identify Potent Antimicrobial Agents from Calotropis procera: Insight into Pharmacophore Modeling, Molecular docking, MD simulation, and DFT Approaches | 1-gen-2024 | Rashid, M.; Sajjad, N.; Shafiq, N.; Parveen, S.; Khan, R. A.; Farooq, A.; Shaha, M.; Dawoud, T. M.; Brogi, S.; Bourhia, M. | |
| Natural products as non-covalent and covalent modulators of the KEAP1/NRF2 pathway exerting antioxidant effects | 1-gen-2024 | Culletta, G.; Buttari, B.; Arese, M.; Brogi, S.; Almerico, A. M.; Saso, L.; Tutone, M. | |
| Synthesis, enzyme inhibition assay, and molecular modeling study of novel pyrazolines linked to 4-methylsulfonylphenyl scaffold: antitumor activity and cell cycle analysis | 1-gen-2024 | Abdel-Aziz, A. A.; El-Azab, A. S.; Brogi, S.; Ayyad, R. R.; Alkahtani, H. M.; Abuelizz, H. A.; Al-Suwaidan, I. A.; Al-Obaid, A. M. | |
| Targeting Relevant HDACs to Support the Survival of Cone Photoreceptors in Inherited Retinal Diseases: Identification of a Potent Pharmacological Tool with In Vitro and In Vivo Efficacy | 1-gen-2024 | Carullo, G.; Orsini, N.; Piano, I.; Pozzetti, L.; Papa, A.; Fontana, A.; Napoli, D.; Corsi, F.; Marco, B. D.; Galante, A.; Marotta, L.; Panzeca, G.; O'Brien, J.; Sanchez, A. G.; Doherty, H.; Mahon, N.; Clarke, L.; Contri, C.; Pasquini, S.; Gorelli, B.; Saponara, S.; Valoti, M.; Vincenzi, F.; Varani, K.; Ramunno, A.; Brogi, S.; Butini, S.; Gemma, S.; Kennedy, B. N.; Gargini, C.; Strettoi, E.; Campiani, G. | |
| Characterization of stenocephol from Seriphidium stenocephalum as potent HepG2 cell growth and glycogen phosphorylase inhibitor | 1-gen-2023 | Shafiq, N.; Arshad, U.; Brogi, S.; Rashid, M.; Rafiq, N.; Parveen, S. | |
| Computation to Fight SARS-CoV-2 (COVID-19) | 1-gen-2023 | Brogi, S.; Calderone, V. | |
| Design, synthesis, and biological investigation of oxadiazolyl, thiadiazolyl, and pyrimidinyl linked antipyrine derivatives as potential non-acidic anti-inflammatory agents | 1-gen-2023 | Al-Sanea, M. M.; Hamdi, A.; Brogi, S.; S Tawfik, S.; Othman, D. I. A.; Elshal, M.; Ur Rahman, H.; Parambi, D. G. T.; M Elbargisy, R.; Selim, S.; Mostafa, E. M.; Mohamed, A. A. B. | |
| Development of Quinazolinone Derivatives as Modulators of Virulence Factors of Pseudomonas aeruginosa Cystic Fibrosis Strains | 1-gen-2023 | Carullo, G.; Di Bonaventura, G.; Rossi, S.; Lupetti, V.; Tudino, V.; Brogi, S.; Butini, S.; Campiani, G.; Gemma, S.; Pompilio, A. | |
| Developmental landscape of computational techniques to explore the potential phytochemicals from Punica granatum peels for their antioxidant activity in Alzheimer’s disease | 1-gen-2023 | Parveen, S.; Batool, A.; Shafiq, N.; Rashid, M.; Sultan, A.; Wondmie, G. F.; Bin Jardan, Y. A.; Brogi, S.; Bourhia, M. | |
| Discovery of novel direct small-molecule inhibitors targeting HIF-2α using structure-based virtual screening, molecular dynamics simulation, and MM-GBSA calculations | 1-gen-2023 | Yazdani, B.; Sirous, H.; Enguita, F. J.; Brogi, S.; Wing, P. A. C.; Fassihi, A. | |
| Disruption of Irisin Dimerization by FDA-Approved Drugs: A Computational Repurposing Approach for the Potential Treatment of Lipodystrophy Syndromes | 1-gen-2023 | Flori, L.; Brogi, S.; Sirous, H.; Calderone, V. |